1 / 8
Laboratory Research Material
AOD-9604 + CJC-1295 + Ipamorelin
- Blend composition
-
Compound Per vial AOD-9604 6 mg CJC-1295 3 mg Ipamorelin 3 mg Total per vial 12 mg - Form
- Lyophilized powder
- Packaging
- 1 × 3 mL vial, boxed
- Shipping
- FedEx 2DayShips from the U.S. Estimated arrival2 business days after dispatchWeekday dispatch · 4 p.m. ET cutoff
Delivery details
Estimated for in-stock orders using FedEx 2Day. Weekends and FedEx closures are excluded. Holiday pickups, destination and carrier delays can affect arrival. Alaska and Hawaii may take longer.
Out of stock
Free U.S. shipping on orders $199+
Important
Research Use Notice
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Product Documentation
Details, specifications, and reviews
Description
AOD-9604 + CJC-1295 + Ipamorelin 12 mg blend
Buy AOD/CJC/Ipamorelin blend with 12 mg total labeled material: 6 mg AOD-9604, 3 mg CJC-1295 and 3 mg Ipamorelin. This research blend is supplied as lyophilized powder in one boxed 3 mL vial.
- AOD-9604: 6 mg per vial
- CJC-1295 DAC: 3 mg per vial
- Ipamorelin: 3 mg per vial
- Total blend: 12 mg per vial
Compare the formulation before choosing
The 2:1:1 proportions are by mass, not by number of molecules. AOD-9604 contributes half the labeled total. This differs from the CJC-1295 NO DAC + Ipamorelin 10 mg blend, which contains no AOD-9604 and has 5 mg of each listed ingredient.
The CJC component in this three-peptide blend is CJC-1295 with DAC, reference CAS 446262-90-4. DAC is the albumin-reactive modification. This distinguishes the formulation from the separately listed NO DAC + Ipamorelin blend.
Separate AOD-9604 5 mg and Ipamorelin 5 mg listings provide alternatives when components need to be selected independently.
Research on the individual components
Heffernan and colleagues compared AOD9604 with full-length growth hormone in mice and receptor assays. The fragment did not compete for the hGH receptor in the reported assay. It should not be described as interchangeable with full-length hGH.
CJC development research examined albumin-conjugated GRF analogs, whereas Raun and colleagues characterized Ipamorelin’s growth-hormone-release responses in pituitary-cell and animal models. These papers studied defined individual materials, not this 6:3:3 mg mixture. They do not establish a combined effect or the blend’s stability.
Product records and handling
Open Documents for the available product files. Confirm each component’s identity, the labeled formulation and any component-specific analytical results needed for the intended experiment. A total powder measurement alone cannot establish all three peptide amounts.
Storage and handling requirements must apply to the complete mixture. The 3 mL specification is container capacity, not liquid supplied or an instruction for preparing the material. Any certificate of analysis used in the evaluation should match the actual product and lot.
Additional information
| CAS No. | AOD-9604: 221231-10-3, CJC-1295 DAC: 446262-90-4, Ipamorelin: 170851-70-4 |
|---|---|
| Purity | ≥99% |
| Synthesis | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. |
| Applications | In-vitro assay research, compound characterization, analytical method development |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
Only logged in customers who have purchased this product may leave a review.
Product documents
Product information and laboratory resources for this product.
Product & packaging information
Labeled amount, physical form and packaging for AOD-9604 + CJC-1295 + Ipamorelin.
Revision 0.4 · 2026-10-05Download PDFLaboratory handling guide
General guidance for applicable lyophilized research materials. Not a product-specific SDS.
Revision 1.0 · 2026-09-22Download PDFGeneral guides & resources
Reading a COA & Verifying Your Lot
PDF · Revision 1.0Receiving, Storage & Traceability Record
PDF · Revision 1.0Research Use & Documentation Scope
PDF · Revision 1.0Need Assistance?
Questions about product documentation?
Our support team can assist with product records, lot information, order questions, and certificate verification.

There are no reviews yet.